30+ YEARS IN NEUROTECH
Empowering brain health through innovation, science and partnerships
Neuromotion is an end-to-end, vertically integrated neurotechnology group — spanning R&D, production, regulatory management, global commercial reach, and early-stage venture building within one unified ecosystem.
Neuro³
NEUROSCIENCE · NEURODIAGNOSTICS · NEUROMODULATION
6+
GLOBAL SUBSIDIARIES
3
UNIFIED BUSINESS MODELS
ISO
13485 CERTIFIED
ABOUT NEUROMOTION
Driven by innovation
Leading by excellence
Neuromotion develops, produces and commercializes research-grade neurotechnology solutions to a global network of partners and customers. We also provide end-to-end technological and commercial services.
Across our platforms, we link excellence in development, regulatory and quality management, and production with our global access to customer experience and feedback, as well as continued innovation growing from our global networks in research, academia, and business.
We also enable access to innovation through strategic partnerships and venture engagement. With a global presence and a track record in both research and clinical environments, we deliver scalable, research-grade and clinically relevant solutions across the neurotechnology landscape.
EEG MEG TMSA flywheel of innovation, market access and business integration
Three pillars of value creation in Neurotechnology
Your Provider of Integrated Neurotechnology Solutions
ANT Neuro is a globally acting provider of Neurotechnology solutions for clinical and research applications in neurodiagnostics and beyond.
ANT Neuro's portfolio includes integrated EEG hardware and software solutions, neuronavigation solutions, and partnered health solution portfolios for medical and non-medical use.
Visit ANT Neuro
Your Neurotech Innovation Hub
eemagine GmbH is a Berlin-based, ISO 13485-certified Centre of Expertise for the Development, Production, Regulatory and Quality management of advanced medical imaging and neurotechnology solutions.
eemagine excels in creating innovative medical products and operates projects from conception to production serving a global client base.
Visit eemagine
Your Selected Neurotech Venture Builder
Neuromotion Ventures engages in neurotechnology start-ups from the pre-seed to seed phase, acting as a partner at different levels: founder, equity partner, and business accelerator.
Activities span hardware and software portfolios across Alzheimer's, Stroke, Mental health, Parkinson's disease, epilepsy, OCD, and chronic pain.
Visit NM VenturesOUR PLATFORM
One ecosystem
End-to-end capability
We are glad to engage — connecting your goals with our global network, deep expertise, and integrated capabilities across the full neurotechnology value chain. From concept to market, regulation to commercialisation.
Deep R&D Expertise
ISO 13485-certified development and production capabilities, from early prototype to clinical-grade product — all under one roof.
Global Market Footprint
Subsidiaries across Europe, North America, APAC, and Australia — with established channels in research, clinical, and commercial markets.
Innovation Network
Access to a global network of researchers, academics, and clinicians that informs product development and accelerates adoption.
Venture Access
Strategic partnerships and pre-seed to seed venture engagement that enables access to the next generation of neurotech innovation.